Literature DB >> 7920669

Complications of Teflon injection for stress urinary incontinence.

P J Kiilholma1, M B Chancellor, J Makinen, I H Hirsch, P J Klemi.   

Abstract

Four significant complications of Teflon injections for stress urinary incontinence are reported in 22 women and eight men. Three of the complications included periurethral abscess, urethral diverticulum, and periurethral Teflon granuloma with urethral wall prolapse occurred in women. These complications needed surgical excision and further surgery for stress incontinence, in two patients the outcome was good. Among the female patients the cure rate for stress incontinence with Teflon injection was only 18% in the 5-year follow-up. One other complication, a Teflon cyst, occurred in a male who had previously undergone radical retropubic prostatectomy. Only two of the eight men (25%) who received Teflon injections had maintained improvement after 1 year.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7920669     DOI: 10.1002/nau.1930120206

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  12 in total

1.  Current use of injectable agents for female stress urinary incontinence.

Authors:  Sender Herschorn
Journal:  Rev Urol       Date:  2005

2.  Advances in the understanding of sress urinary incontinence and the promise of stem-cell therapy.

Authors:  Akira Furuta; Lesley K Carr; Naoki Yoshimura; Michael B Chancellor
Journal:  Rev Urol       Date:  2007

3.  1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence.

Authors:  L K Carr; D Steele; S Steele; D Wagner; R Pruchnic; R Jankowski; J Erickson; J Huard; M B Chancellor
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06

Review 4.  Adipose tissue and lipid droplet embolism following periurethral injection of autologous fat: case report and review of the literature.

Authors:  I Currie; H P Drutz; J Deck; D Oxorn
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

5.  Controlled release of insulin-like growth factor 1 enhances urethral sphincter function and histological structure in the treatment of female stress urinary incontinence in a rat model.

Authors:  Hao Yan; Liren Zhong; Yaodong Jiang; Jian Yang; Junhong Deng; Shicheng Wei; Emmanuel Opara; Anthony Atala; Xiangming Mao; Margot S Damaser; Yuanyuan Zhang
Journal:  BJU Int       Date:  2017-10-03       Impact factor: 5.588

6.  Obstructive suburethral mass after transurethral injection of dextranomer/hyaluronic acid copolymer.

Authors:  Hassan A Abdelwahab; Gamal M Ghoniem
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-04-17

7.  Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study.

Authors:  Philippe Sèbe; Christelle Doucet; Jean-Nicolas Cornu; Calin Ciofu; Pierre Costa; Sixtina Gil Diez de Medina; Christian Pinset; Francois Haab
Journal:  Int Urogynecol J       Date:  2010-09-07       Impact factor: 2.894

8.  Bulking agent induced early urethral prolapse after distal urethrectomy.

Authors:  Edmund Y Ko; Bryant F Williams; Steven P Petrou
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-09-01

Review 9.  Muscle derived stem cell therapy for stress urinary incontinence.

Authors:  Marc C Smaldone; Michael B Chancellor
Journal:  World J Urol       Date:  2008-05-10       Impact factor: 4.226

10.  Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence.

Authors:  H Strasser; R Marksteiner; E Margreiter; M Mitterberger; G M Pinggera; F Frauscher; M Fussenegger; K Kofler; G Bartsch
Journal:  World J Urol       Date:  2007-08-14       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.